Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase III study of nolasiban for in-vitro fertilisation

Trial Profile

Phase III study of nolasiban for in-vitro fertilisation

Planning
Phase of Trial: Phase III

Latest Information Update: 03 Oct 2018

At a glance

  • Drugs Nolasiban (Primary)
  • Indications Female infertility
  • Focus Therapeutic Use
  • Acronyms IMPLANT3
  • Most Recent Events

    • 03 Oct 2018 According to an ObsEva media release company has received feedback from two European regulatory authorities.Pending positive outcome of an additional Phase 3 trial, both regulatory bodies have agreed to a proposed MAA that will include IMPLANT 1 and IMPLANT 2 trial results, as well as results from the additional Phase 3 clinical trial.MAA submission is anticipated by the end of 2019.
    • 08 Aug 2018 According to an ObsEva media release, the company expects to initiate this trial by the end of 2018.
    • 25 May 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top